2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)thiazole-5-carbonitrile,
GLPG1690,
GLPG1690,
1628260-79-6,
GLPG-1690,
Ziritaxestat,
CHEMBL3828074,
UNII-I02418V13W,
I02418V13W,
2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile,
GTPL9561,
SCHEMBL16051264,
BCP20895,
EX-A1646,
BDBM50187686,
MFCD31544330,
AKOS032946267,
CS-7634,
SB19736,
compound 11 [PMID: 28414242],
AK687397,
HY-101772,
J3.652.431F,
2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile,
GLPD-1690,
REQQVBGILUTQNN-UHFFFAOYSA-N,
2-[[2-Ethyl-8-Methyl-6-[4-[2-(3-Oxidanylazetidin-1-Yl)-2-Oxidanylidene-Ethyl]piperazin-1-Yl]imidazo[1,2-A]pyridin-3-Yl]-Methyl-Amino]-4-(4-Fluorophenyl)-1,3-Thiazole-5-Carbonitrile,
5-Thiazolecarbonitrile, 2-((2-ethyl-6-(4-(2-(3-hydroxy-1-azetidinyl)-2-oxoethyl)-1-piperazinyl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)-,
N/A,